logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

PembrolizumabMyasthenia gravis: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2024年 / 2033卷 / 1期
关键词:
D O I:
10.1007/s40278-024-70343-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:233 / 233
相关论文
共 50 条
  • [41] PembrolizumabMyasthenia gravis and myositis
    Reactions Weekly, 2024, 2014 (1) : 554 - 554
  • [42] Immune-globulin/methylprednisolone/pembrolizumabMyasthenia-gravis and lack of efficacy: case report
    Reactions Weekly, 2021, 1870 (1) : 159 - 159
  • [43] PembrolizumabMyasthenia gravis, myositis and myocarditis
    Reactions Weekly, 2024, 2014 (1) : 555 - 555
  • [44] SotalolMyasthenia gravis: case report
    Reactions Weekly, 2019, 1778 (1) : 421 - 421
  • [45] NivolumabMyasthaenia gravis: case report
    Reactions Weekly, 2019, 1773 (1) : 257 - 257
  • [46] RegorafenibMyasthenia gravis: case report
    Reactions Weekly, 2023, 1953 (1) : 350 - 350
  • [47] NivolumabMyasthenia gravis: case report
    Reactions Weekly, 2019, 1774 (1) : 241 - 241
  • [48] HydroxychloroquineMyasthenia gravis: case report
    Reactions Weekly, 2019, 1737 (1) : 152 - 152
  • [49] PenicillamineMyasthenia gravis: case report
    Reactions Weekly, 2012, 1424 (1) : 41 - 41
  • [50] TislelizumabMyasthenia gravis: case report
    Reactions Weekly, 2024, 2025 (1) : 437 - 437
← 12345 →